News

A team of researchers combined behavioral observations of wild chimpanzees with pharmacological testing of the potentially medicinal plants they eat. They monitored the behavior and health of 51 chimpanzees from two communities.

An enzyme-based treatment developed by Yale researchers mitigated autoimmunity and reduced death rates in both genetic and non-genetic mouse lupus models, a new study reveals.

Scientists at the Brain Tumour Research Centre of Excellence at the University of Plymouth are conducting a clinical trial to see whether using anti-retroviral medications, Ritonavir and Lopinavir, could help people with Neurofibromatosis 2 (NF2).

"Smart bandages" that can automatically sense and respond to changes in a wound could revolutionize chronic wound treatment, including diabetic ulcers and surgical wounds.

Researchers studied how the pathogenic bacterium Escherichia coli reacts when exposed to small, non-fatal amounts of the antibiotic Ciprofloxacin.

Oregon is first in the nation to provide state-regulated access to magic mushrooms; study is first to identify measures for high-quality services.

When low doses of cancer drugs are administered continuously near malignant brain tumors using so-called iontronic technology, cancer cell growth drastically decreases.

A new study suggests that certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies (DLB).

A new study explores how polycystic ovary syndrome (PCOS) impacts the immune system, revealing that immune cell populations were affected across reproductive, metabolic and immunological tissues in different ways.

A Kobe University study of how the treatment acts on the immune system shows that it shifts the balance of types of immune cells. This finding may represent a step toward the development of personalized medicine for autoimmune diseases.